// App-Quantinova.ai

: Frequency Persistence and Patient reported Outcomes of Neurological Symptoms in Mild COVID 19 Results from the ALBERTA HOPE COVID 19 Trial

Researchers

Presenter

  • Aravind Ganesh

Principal Investigators

  • Ryan Rosentreter

  • Yushi Chen

  • Rahul Mehta

  • Graham McLeod

  • Miranda Wan

  • Jonathan Krett

  • Yasamin Mahjoub

  • Angela Lee

  • Ilan Schwartz

  • Luanne Metz

  • Eric E. Smith

  • Michael D. Hill

Medical Centers

  • Department of Clinical Neurosciences, University of Cambridge, UK

  • Faculty of Medicine & Dentistry, University of Alberta

  • Department of Medicine, University of Alberta, Alberta, AK

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • NCT04329611

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved